Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Co-Organizer of upcoming S.E.E Summit interviews with AVRT
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(36)
•••
Post by LithLoveron Apr 20, 2022 5:35pm
166 Views
Post# 34618186

Co-Organizer of upcoming S.E.E Summit interviews with AVRT

Co-Organizer of upcoming S.E.E Summit interviews with AVRT
Posted on Stage's LinkedIn.  S.E.E Summit tomorrow April 21, 2022
--------------------
Healthy Conversations was thrilled to have hosted Jamie Reno on this month's Podcast. Jamie is an acclaimed journalist, bestselling author, patient advocate and three-time survivor of stage IV cancer. He is also co-organizer of the inaugural S.E.E. Summit, a virtual conference to be held on April 21, 2022 by Teen Cancer America (TCA). The summit will feature presentations by the leading researchers and oncologists from biotechnology companies that are turning the game-changing promise of liquid biopsies into reality. Online attendance is free, and registration is available at https://lnkd.in/gr2DQTXc

Watch The Interview
https://ow.ly/LCmG50IN0tR


https://www.youtube.com/watch?v=Fs3EaVPmFSs
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities